MERONI, MARICA
MERONI, MARICA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
The KLB rs12152703 variant confers protection against hepatic inflammation in patients with MASLD by boosting Klotho-beta expression
2026 M. Meroni, N. Panera, E. Paolini, M. Longo, F. Tiano, C. De Stefanis, V. D'Oria, A. Mosca, S. Badiali, M. Maggioni, E. Mosca, A.L. Fracanzani, A. Alisi, P. Dongiovanni
Single Cell Analysis Reveals the Presence of Novel Intermediate Cells in Both Mice and Patients With Severe MASLD
2026 M. Meroni, P. Pelucchi, E. Paolini, M. Longo, A. Sula, M. Battistin, A. Chiodi, D. Mattinzoli, M. Ikehata, E. Trombetta, D. Dondossola, A. Mezzelani, G.M. Tartaglia, G. Castellano, A.L. Fracanzani, F. Peyvandi, S. Gatti, E. Mosca, P. Dongiovanni
Next Generation Sequencing Allows Identification of a Novel Mutation in the TfR2 Gene and Outperforms the Conventional Diagnostic Techniques
2025 M. Longo, E. Paolini, M. Meroni, F. Cinque, C. Bertelli, G. Pisano, M. Maggioni, A.L. Fracanzani, R. Lombardi, P. Dongiovanni
Exploring multiorgan mitochondrial dysfunction in the switch toward progressive MASLD in AMLN mice
2025 M. Meroni, E. Paolini, M. Longo, M. Battistin, D. Dondossola, M. Ripolone, L. Napoli, E. Mosca, S. Corti, P. Dongiovanni
Artificial intelligence as a ploy to delve into the intricate link between genetics and mitochondria in patients with MASLD
2025 M. Longo, E. Paolini, M. Meroni, M. Ripolone, L. Napoli, F. Gentile, A. Cespiati, E. Trombetta, R. Lombardi, M. Maggioni, A. Alisi, L. Miele, A. Liguori, G. Soardo, A. Gasbarrini, M. Moggio, A.L. Fracanzani, P. Dongiovanni
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease
2023 R.M. Pipitone, F. Malvestiti, G. Pennisi, O. Jamialahmadi, P. Dongiovanni, G. Bertolazzi, J. Pihlajamäki, H. Yki-Järvinen, U. Vespasiani-Gentilucci, F. Tavaglione, S. Maurotti, C. Bianco, G. Di Maria, M. Enea, A.L. Fracanzani, V. Kärjä, G. Lupo, V. Männistö, M. Meroni, R. Piciotti, S. Qadri, R. Zito, A. Craxì, V. Di Marco, C. Cammà, C. Tripodo, L. Valenti, S. Romeo, S. Petta, S. Grimaudo
Recent advances of drugs monitoring in oral fluid and comparison with blood
2023 S. Casati, M. Binda, P. Dongiovanni, M. Meroni, A. D'Amato, G. Roda, M. Orioli, M. DEL FABBRO, G.M. Tartaglia
Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation
2023 P. Dongiovanni, M. Meroni, S. Casati, R. Goldoni, D.V. Thomaz, N.S. Kehr, D. Galimberti, M. Del Fabbro, G.M. Tartaglia
Notch-mediated hepatocyte MCP-1 secretion causes liver fibrosis
2023 J. Kang, J. Postigo-Fernandez, K. Kim, C. Zhu, J. Yu, M. Meroni, B. Mayfield, A. Bartolomé, D.H. Dapito, A.W. Ferrante, P. Dongiovanni, L. Valenti, R.J. Creusot, U.B. Pajvani
An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians
2023 A. Cespiati, F. Cinque, M. Meroni, R. Lombardi, P. Dongiovanni, A.L. Fracanzani
Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort" [J Hepatol (2020) 505-515]
2023 Q. M Anstee, R. Darlay, S. Cockell, M. Meroni, O. Govaere, D. Tiniakos, A. D Burt, P. Bedossa, J. Palmer, Y. Liu, G. P Aithal, M. Allison, H. Yki-Järvinen, M. Vacca, J. Dufour, P. Invernizzi, D. Prati, M. Ekstedt, S. Kechagias, S. Francque, S. Petta, E. Bugianesi, K. Clement, V. Ratziu, J. M Schattenberg, L. Valenti, C. P Day, H. J Cordell, A. K Daly
Circulating indian hedgehog is a marker of the hepatocyte-TAZ pathway in experimental NASH and is elevated in humans with NASH
2023 M.P. Moore, X. Wang, H. Shi, M. Meroni, A. Cherubini, L. Ronzoni, E.J. Parks, J.A. Ibdah, R.S. Rector, L. Valenti, P. Dongiovanni, I. Tabas
The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value
2023 E. Paolini, M. Longo, M. Meroni, G. Tria, A. Cespiati, R. Lombardi, S. Badiali, M. Maggioni, A.L. Fracanzani, P. Dongiovanni
Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemia
2022 M. Meroni, M. Longo, E. Paolini, G. Tria, M. Ripolone, L. Napoli, M. Moggio, A.L. Fracanzani, P. Dongiovanni
Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies
2022 A. Cespiati, M. Meroni, R. Lombardi, G. Oberti, P. Dongiovanni, A.L. Fracanzani
Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b
2022 S.J. Patel, N. Liu, S. Piaker, A. Gulko, M.L. Andrade, F.D. Heyward, T. Sermersheim, N. Edinger, H. Srinivasan, M.P. Emont, G.P. Westcott, J. Luther, R.T. Chung, S. Yan, M. Kumari, R. Thomas, Y. Deleye, A. Tchernof, P.J. White, G.A. Baselli, M. Meroni, D.F. De Jesus, R. Ahmad, R.N. Kulkarni, L. Valenti, L. Tsai, E.D. Rosen
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models
2022 M. Longo, M. Meroni, E. Paolini, V. Erconi, F. Carli, F.R. Fortunato, D. Ronchi, R. Piciotti, S. Sabatini, C. Macchi, A. Alisi, L. Miele, G. Soardo, G.P. Comi, L.V.C. Valenti, M. Ruscica, A.L. Fracanzani, A. Gastaldelli, P. Dongiovanni
Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system
2022 M. Meroni, E. Paolini, M. Longo, R. Piciotti, G. Tria, S. Fargion, A. Ludovica Fracanzani, P. Dongiovanni
MAFLD definition underestimates the risk to develop HCC in genetically predisposed patients
2022 M. Meroni, M. Longo, E. Paolini, R. Lombardi, R. Piciotti, P. Francione, S. Badiali, M. Maggioni, A.L. Fracanzani, P. Dongiovanni
{PD}-1/{PD}-L1 Immuno-Mediated Therapy in {NAFLD}: Advantages and Obstacles in the Treatment of Advanced Disease
2022 R. Lombardi, R. Piciotti, P. Dongiovanni, M. Meroni, S.R. Fargion, A.L. Fracanzani